Erectile Dysfunction Background – which percent of men?

Erectile dysfunction affects 50 percent of men who are older than 40 years of age. This exerts huge effects on the quality of life. This problem is very common and highly complex with full of multiple pathways. Penile erections are produced by an integration of physiological processes which involve the peripheral nervous, central nervous, hormonal and vascular systems. Whether from drug or disease, any abnormality in these systems has an important effect on the ability to develop and keep an erection, ejaculate and experience orgasm.

A common and imperative cause of erectile dysfunction is vasculogenic. Majority of men with erectile dysfunction have comorbid conditions such as hypercholesterolemia, hyperlipidemia, tobacco abuse, diabetes mellitus or coronary artery disease (CAD). A researcher recommends screening men who have erectile dysfunction for cardiovascular risk factors; this erectile dysfunction may be the earliest presentation of vascular disease and atherosclerosis.

In addition, the physiological processes entail erections start at the genetic level. Particular genes become activated at critical times to give proteins vital to sustaining this pathway. Some researchers have concentrated on detecting certain genes that place men at risk for erectile dysfunction. At the moment, these researches are limited to animal models and the little success has been updated. Notwithstanding, this studies have given rise to many new therapy focuses and a better knowledge of the whole process.

The first step in treating the patient who is suffering from erectile dysfunction is to take a serious sexual, medical and psychological history. Questionnaires are made available to help the doctors in getting essential data of the patient. Successful treatment of sexual dysfunction has been demonstrated to improve sexual aspects of quality of life, improve entire life quality and relieve the symptoms of depression.

The availability of PDE5 inhibitors – sildenafil, vardenafil, tadalafil and avanafil has basically changed the medical management of erectile dysfunction. Additionally, direct-to-consumer marketing of these agents for the past 15 years has increased the general awareness of the public on erectile dysfunction as a medical condition with underlying causes and effective treatments. It is unfortunate that some patients may have an overly simplified understanding of the role of PDE5 inhibitors in erectile dysfunction management. Such patients may not expect or be ready to undergo a long evaluation and testing process to get a better understanding of their sexual issue and they may less likely to involve their partner in the discussion of their sexual relationship with the doctor. They may expect to get medications through a phone call to their doctor or even over the internet with minimal or no physician contact at all. In this case, the doctor’s role may have to include efforts to educate the patients about realistic sexual expectations. These efforts can help to prevent the misuse or overuse of these remarkable drugs.